Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.83
- Piotroski Score 6.00
- Grade Neutral
- Symbol (AMED)
- Company Amedisys, Inc.
- Price $90.62
- Changes Percentage (0.51%)
- Change $0.46
- Day Low $90.00
- Day High $90.71
- Year High $98.95
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $162.50
- High Stock Price Target $190.00
- Low Stock Price Target $85.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.64
- Trailing P/E Ratio -143.36
- Forward P/E Ratio -143.36
- P/E Growth -143.36
- Net Income $-9,747,000
Income Statement
Quarterly
Annual
Latest News of AMED
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Old Dominion Reveals the Sweet Reason their Wardrobe Boxes Are Named After Members of Little Big Town (Exclusive)
Old Dominion won their seventh vocal group of the year award at the 2024 CMA Awards, beating out Little Big Town. Despite the competition, the bands share a close bond, with Old Dominion still using w...
By PEOPLE.com | 1 day ago -
Mass poisoning blamed on tainted alcohol with American among four tourists dead
An American citizen died in Laos due to methanol-tainted alcohol. Australian and Danish citizens also perished. Authorities warn of the dangers of tainted drinks in Vang Vieng, urging caution to trave...
By NBC News | 1 day ago -
Pittsburgh restaurant named one of the best in America by OpenTable
Morcilla in Pittsburgh's Lawrenceville neighborhood has been named one of the top 100 restaurants in America for 2024 by OpenTable. Known for Spanish-inspired dishes, it was chosen based on diner revi...
By CBS News | 1 day ago
